Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Septerna, Inc.(SEPN) | 6,215,591 | 6,068,391 | -147,200 | $208.16M | $237.46M | 49.99% | +$29.30M |
| Rapport Therapeutics, Inc.(RAPP) | 6,280,525 | 6,280,525 | 0 | $261.71M | $211.03M | 44.43% | -$50.68M |
| Maze Therapeutics, Inc.(MAZE) | 950,800 | 950,800 | 0 | $28.37M | $25.84M | 5.44% | -$2.53M |
| Lisata Therapeutics, Inc. | 0 | 455,192 | +455,192 | $0 | $655.5K | 0.14% | +$655.5K |